As expected, the tumor sample population showed higher expression levels of pro-mitotic genes such as CCNB1 and MYBL2, genes that modulate the host immune response, such as SERPINB3, and the tight-junctions proteins claudin-4 and claudin-6, which are often deregulated in cancers. Here, CCNB1 is linked to cancer.